MedPath

Shanghai Jiaotong Medical University Attached Ruijin Hospital

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

A Single-cell Transcriptome Study in Patients With Non-Hodgkin's Lymphoma

Conditions
Non Hodgkin Lymphoma
First Posted Date
2020-06-17
Last Posted Date
2020-07-07
Lead Sponsor
Ruijin Hospital
Target Recruit Count
150
Registration Number
NCT04434833
Locations
🇨🇳

Shanghai Ruijin Hospital, Shanghai, China

Pre-Operative Pembrolizumab + Chemoradiation in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma

Phase 2
Completed
Conditions
Esophageal Squamous Cell Carcinoma
Interventions
First Posted Date
2020-06-17
Last Posted Date
2024-07-03
Lead Sponsor
Ruijin Hospital
Target Recruit Count
143
Registration Number
NCT04435197
Locations
🇨🇳

Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, Shanghai, China

🇨🇳

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China

Neoadjuvant Chemotherapy With PISOXO for Locally-invaded-gastric Cancer (LIGC)

Phase 1
Conditions
Stomach Cancer
Gastric Cancer
Interventions
Drug: PIPAC+SOX+OLAPARIB
First Posted Date
2020-06-01
Last Posted Date
2020-06-01
Lead Sponsor
Ruijin Hospital
Target Recruit Count
30
Registration Number
NCT04410887
Locations
🇨🇳

Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China

Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary Tumors

Not Applicable
Conditions
Cholangiocarcinoma, Extrahepatic
Pancreatic Endocrine Tumors
Chronic Pancreatitis
Duodenal Adenocarcinoma
Pancreatic Adenocarcinoma
Pancreatic Cysts
Ampullary Adenocarcinoma
Interventions
Procedure: Open pancreaticoduodenectomy
Procedure: Robotic pancreaticoduodenectomy
First Posted Date
2020-05-22
Last Posted Date
2022-05-03
Lead Sponsor
Ruijin Hospital
Target Recruit Count
244
Registration Number
NCT04400357
Locations
🇨🇳

Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China

The Safety and Effectiveness of Cholinergic Receptor Block Therapy in the Treatment of ALS

Phase 2
Conditions
Respiratory Function
Amyotrophic Lateral Sclerosis
Scopolamine
Interventions
First Posted Date
2020-05-18
Last Posted Date
2020-10-14
Lead Sponsor
Ruijin Hospital
Target Recruit Count
30
Registration Number
NCT04391361
Locations
🇨🇳

Department of neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China

the Safety and the Efficacy Evaluation of Allogenic Adipose MSC-Exos in Patients With Alzheimer's Disease

Phase 1
Conditions
Alzheimer Disease
Interventions
Biological: mild dosage MSCs-Exos administrated for nasal drip
Biological: high dosage MSCs-Exos administrated for nasal drip
Biological: low dosage MSCs-Exos administrated for nasal drip
First Posted Date
2020-05-15
Last Posted Date
2021-06-25
Lead Sponsor
Ruijin Hospital
Target Recruit Count
9
Registration Number
NCT04388982
Locations
🇨🇳

Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China

Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer

Phase 3
Not yet recruiting
Conditions
Gastric Cancer
Neoadjuvant Chemotherapy
Interventions
Drug: Chemotherapy
First Posted Date
2020-05-12
Last Posted Date
2021-07-19
Lead Sponsor
Ruijin Hospital
Target Recruit Count
246
Registration Number
NCT04384601
Locations
🇨🇳

Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China

A Tolerance Clinical Study on Aerosol Inhalation of Mesenchymal Stem Cells Exosomes In Healthy Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Biological: 2X level of MSCs-Exo
Biological: 1X level of MSCs-Exo
Biological: 4X level of MSCs-Exo
Biological: 6X level of MSCs-Exo
Biological: 8X level of MSCs-Exo
First Posted Date
2020-03-18
Last Posted Date
2021-08-04
Lead Sponsor
Ruijin Hospital
Target Recruit Count
24
Registration Number
NCT04313647
Locations
🇨🇳

Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China

Different Anti-Spastic Therapy Strategies After CABG Using Radial Artery Grafts

Phase 4
Completed
Conditions
Antispastic Therapy
Coronary Artery Bypass Graft
Radial Artery Grafts
Pilot Study
Interventions
First Posted Date
2020-03-17
Last Posted Date
2024-12-12
Lead Sponsor
Ruijin Hospital
Target Recruit Count
150
Registration Number
NCT04310995
Locations
🇨🇳

Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai, China

A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia

Phase 1
Completed
Conditions
Coronavirus
Interventions
Biological: MSCs-derived exosomes
First Posted Date
2020-02-19
Last Posted Date
2020-09-07
Lead Sponsor
Ruijin Hospital
Target Recruit Count
24
Registration Number
NCT04276987
Locations
🇨🇳

Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath